Evidence map›Paper›PMID 34484288›Full record

ArticleFrontiers in genetics2021

Development and Validation of a Forensic Multiplex System With 38 X-InDel Loci.

Ling Chen, Xiyong Pan, Yuan Wang, Weian Du, Weibin Wu, Zhenya Tang, Cheng Xiao, Xiaolong Han, Chao Liu, Changhui Liu

Abstract read
In one paragraph

Article in Frontiers in genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. An Application of ITO Analysis in Secondary Kinship Identification.Computational and mathematical methods in medicine · 2022
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ling ChenSchool of Forensic Medicine, Southern Medical University, Guangzhou, China.
Xiyong PanSchool of Forensic Medicine, Sun Yat-sen University, Guangzhou, China.
Yuan WangSchool of Forensic Medicine, Southern Medical University, Guangzhou, China.
Weian DuGuangdong Homy Genetics Incorporation, Foshan, China.
Weibin WuGuangdong Homy Genetics Incorporation, Foshan, China.
Zhenya TangGuangdong Provincial Forensic Science Center, Guangzhou, China.
Cheng XiaoGuangzhou Forensic Science Institute, Guangzhou, China.
Xiaolong HanGuangzhou Forensic Science Institute, Guangzhou, China.
Chao LiuSchool of Forensic Medicine, Southern Medical University, Guangzhou, China.
Changhui LiuSchool of Forensic Medicine, Southern Medical University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the present study, a novel multiplex system, AGCU X-InDel 38 kit, was designed to amplify 38 X-InDel markers and amelogenin in a single Polymerase Chain Reaction (PCR). To demonstrate the suitability and efficiency for forensic applications, a series of validation experiments were conducted, including sensitivity, species specificity, reproducibility, stability, case samples, balance of peak height, size precision, as well as allele frequency and forensic parameter analysis. The results showed that AGCU X-InDel 38 kit was capable to get full profiles even with 62.5 pg of template DNA, and full profiles can be obtained when hematin concentration ≤25 μmol/L, or hemoglobin concentration ≤50 μmol/L, showing good tolerance to six common inhibitors. Moreover, the analyzed case samples indicated that AGCU X-InDel 38 kit had better performance for degraded and trace DNA samples. The 200 unrelated males from Guangdong Han population showed that the combined PD

Indexed as

forensic geneticsInDelmultiplex PCRvalidationX chromosome

Identifiers

PMID34484288
PMCPMC8416044

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.